Pradaxa ® (dabigatran etexilate) drives Boehringer Ingelheim ' s innovation promise in cardiovascular diseases

Pradaxa ® (dabigatran etexilate) drives Boehringer Ingelheim ' s innovation promise in cardiovascular diseases
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news